Pfizer, which set out to strengthen its business last year by acquiring rival drug maker Wyeth, said today its fourth quarter sales ballooned by 34 percent. Wyeth’s legacy products, such as the ...

Vaccine maker Wyeth-Ayerst Laboraties agreed to pay a $30-million fine for repeatedly violating federal drug-quality rules at two of its East Coast manufacturing plants, including a flu-shot ...

The Wyeth Family of Artists' 10 a.m.-5 p.m. daily. Through Dec. 31. Farnsworth Museum, 16 Museum St., Rockland, $20, $18 seniors, $10 students 17 and older, free for 16 and under and Rockland ...

American Home Products Corp. is changing its name to Wyeth after 76 years, to reflect the company's focus on research-based pharmaceutical products.

PREMIUM PRODUCTS. TheStreet Pro Login Subscribe Portfolio (AAP) Latest (All Real Money Pro Authors) Doug's Daily Diary Pro Column: Top Stocks Pro Column: Stocks Under $10 What's New. CATEGORIES.

Pfizer's earnings rose 9.5% as the company's revenue was again boosted by its acquisition of Wyeth while sales of its flagship drugs rose.

Federal preemption arguments failed in October to prevent a Nevada jury from awarding three women $134.5 million in their suit against Wyeth over its hormone replacement products Premarin and Prempro ...

Hefty charges and a higher tax rate, both related to the $68 billion purchase of Wyeth, dragged the drugmaker's profit down 70 percent, the company said Tuesday.

Drugmaker Pfizer Beats Profit, Revenue Expectations In 4Q, New CEO Outlines Strategy Overhaul ...

BOSTON (MarketWatch) -- Johnson & Johnson and Wyeth said Thursday that they were voluntarily pulling several cold medications for babies from shelves, due to reports that some children had been ...

Pfizer Inc. is buying rival drugmaker Wyeth in a $68 billion deal that will increase its revenue by 50 percent, solidify its No. 1 rank in the troubled industry and transform it from a pure ...

Credit Suisse First Boston maintained a "neutral" rating on Wyeth after the drugmaker announced strong earnings guidance for the third quarter. Wyeth said third-quarter pro forma earnings per ...